Navigation Links
New study of the world's smallest elephant

The world's smallest elephant species, the newly described Bornean elephant, will be the focus of a Cardiff University study in Sabah, Malaysia for the next three years.

The Bornean elephant has recently been confirmed as a separate sub-species, dramatically increasing its importance for biodiversity. Bornean elephants are the world's most endangered member of the elephant family with an estimated 1,100 - 1,500 surviving in the wild.

The Cardiff School of Biosciences study led by Professor Michael Bruford and funded by the Department of Environment, Food and Rural Affairs, will provide the Sabah Wildlife Department with a range of essential conservation and management information concerning the ecology, genetics, social structure, dispersal and conflicts with agriculture.

Dr Benoît Goossens who will carry out the research, said the need for the project was identified by wildlife authorities in Sabah during a previous Darwin Initiative grant to study orangutans. He said: "There is clearly an urgent need to undertake sound conservation action. Our work will provide information that is currently lacking, including identification of priority areas for the species that should be kept under forest cover.

"The project will also include training for Malaysian MSc student, Ms Nurzhafarina Othman in population biology and conservation genetics; and training for governmental and non-governmental organisations as well as representatives from the private sector on wildlife monitoring techniques."

Project partners are the Sabah Wildlife Department, Kinabatangan Orang Utan Conservation Project and the Institute for Tropical Biology and Conservation at Universiti Malaysia Sabah.


Source:Cardiff University

Page: 1

Related biology news :

1. Bioartificial kidney under study at MCG
2. W.M. Keck Foundation funds study of friendly microbes
3. Yellowstone microbes fueled by hydrogen, according to U. of Colorado study
4. Genome-wide mouse study yields link to human leukemia
5. Clam embryo study shows pollutant mixture adversely affects nerve cell development
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Same mutation aided evolution in many fish species, Stanford study finds
8. Sequencing of marine bacterium will help study of cell communication
9. Genetically modified rice in China benefits farmers health, study finds
10. A new study examines how shared pathogens affect host populations
11. NYU study reveals how brains immune system fights viral encephalitis
Post Your Comments:

(Date:6/21/2016)... 21, 2016 NuData Security announced today that ... of principal product architect and that Jon ... customer development. Both will report directly to ... moves reflect NuData,s strategic growth in its product ... customer demand and customer focus values. ...
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... YORK , June, 23, 2016  The Biodesign ... to envision new ways to harness living systems and ... Modern Art (MoMA) in New York City ... than 130 participating students, showcased projects at MoMA,s Celeste ... Paola Antonelli , MoMA,s senior curator of architecture ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
Breaking Biology Technology: